Attached files
| file | filename |
|---|---|
| EX-31.2 - EX-31.2 - ALBIREO PHARMA, INC. | albo-ex312_7.htm |
| EX-31.1 - EX-31.1 - ALBIREO PHARMA, INC. | albo-ex311_9.htm |
| 10-Q - 10-Q - ALBIREO PHARMA, INC. | albo-10q_20170630.htm |
Exhibit 32.1
CERTIFICATIONS UNDER SECTION 906
Pursuant to section 906 of the Sarbanes-Oxley Act of 2002 (subsections (a) and (b) of section 1350, chapter 63 of title 18, United States Code), each of the undersigned officers of Albireo Pharma, Inc., a Delaware corporation (the “Company”), does hereby certify, to such officer’s knowledge, that:
The Quarterly Report for the quarter ended June 30, 2017 (the “Form 10-Q”) of the Company fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934, as amended, and the information contained in the Form 10-Q fairly presents, in all material respects, the financial condition and results of operations of the Company.
|
Dated: August 21, 2017 |
|
/s/ Ronald H.W. Cooper |
|
|
|
Ronald H.W. Cooper |
|
|
|
President and Chief Executive Officer (principal executive officer) |
|
Dated: August 21, 2017 |
|
/s/ Thomas A. Shea |
|
|
|
Thomas A. Shea |
|
|
|
Chief Financial Officer and Treasurer (principal financial officer and principal accounting officer) |